- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
- Volume is elevated versus the 13-week average, confirming attention.
FLRY3
SAO
Week ended 07 Aug 2026
Weekly Investor Report
Fleury S.A. · Healthcare · Diagnostics & Research
Latest close
18.95 BRL
10.6%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is 16.9% above the Trend Line and sits at 88.5% of its 52-week range. The latest completed week returned 10.6%, after a 15.4% four-week move. The latest news-sentiment score is 50/100.
Setup score
76
out of 100
Latest Close
18.95 BRL
7 Aug 2026
1W Return
10.6%
latest completed week
4W Return
15.4%
short-term follow-through
12W Return
21.5%
quarterly tape
Trend Breadth
78.8%
41 of 52 weeks active
Volume Ratio
3.0x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- 2 reversal markers appear in the recent smart-money tape.
- Price is close to its 52-week high; watch for continuation or exhaustion.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
10.6%
Latest completed week; four-week move 15.4%.
Indicator stack
43/80
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Positive 55.71%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
50/100
1 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is 16.9% above the Trend Line and sits at 88.5% of its 52-week range. The latest completed week returned 10.6%, after a 15.4% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 3.0x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.4612-week average 0.38
12-week confirmation
Trend active1/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure2/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership4/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.46Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers22 reversal markers
No recent accumulation markers. 2 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 15.4% over four weeks, 21.5% over 12 weeks, and 42.9% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year41
Trend breadth78.8%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.74Latest activity-pressure read.
Pressure change202.6%Four-week change in activity pressure.
Leadership17.71Latest relative-leadership reading.
RS change2164.1%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 1 relevant articles.
0 positive · 1 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-4.0%Distance below the 52-week high.
13-week volatility4.3%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher14 of 2612 weeks finished lower.
Best week+10.6%Week of 7 Aug.
Worst week-5.9%Week of 15 May.
Latest week+10.6%Week of 7 Aug.
Shape of recent returns
Strong gains5
Modest gains9
Flat weeks0
Modest losses8
Sharp losses4
Recent vol4.3%13-week weekly-return volatility.
Base vol3.9%52-week weekly-return volatility.
Up/down split31/21Count of positive and negative weeks in the 52-week window.
Average skew3.3% / -3.0%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorBR Healthcare
4-week rank3 / 82
Group average-0.7%
Trend breadth35.4%
Trend35.4%active weekly trend signals
MD65.9%positive activity pressure
RS46.3%positive relative leadership
Four-week leaders
IndustryBR Diagnostics & Research
4-week rank1 / 10
Group average4.4%
Trend breadth30.0%
Trend30.0%active weekly trend signals
MD90.0%positive activity pressure
RS50.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape70/100
Trend, activity pressure, participation, and risk combine to a 70/100 tape read.
Indicator analysis25/100Latest 12-week confirmation: trend 1/12, activity pressure 2/12, relative leadership 4/12.
Activity pressure 0.46; 2 reversal markers Next-Week ExpectancyPositive 55.71%Next-week expectancy is positive with a 55.71% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 1 relevant articles.
Fleury S.A.: Shareholders Board Members Managers and Company Profile | BRFLRYACNOR5 Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 18.95 BRL | 10.6% | 16.21 BRL | 13.53 BRL | 0.74 | 17.71 | 24.2M | Off |
| 31 Jul 2026 | 17.14 BRL | 5.4% | 16.09 BRL | 13.49 BRL | 0.38 | 3.45 | 9.1M | Off |
| 24 Jul 2026 | 16.26 BRL | -2.0% | 16.02 BRL | 13.46 BRL | -0.09 | 0.31 | 8.1M | Off |
| 17 Jul 2026 | 16.59 BRL | 1.0% | 15.97 BRL | 13.44 BRL | -0.35 | 2.39 | 9.0M | Off |
| 10 Jul 2026 | 16.42 BRL | 4.5% | 15.90 BRL | 13.42 BRL | -0.72 | -0.86 | 13.6M | Off |
| 3 Jul 2026 | 15.72 BRL | 0.7% | 15.86 BRL | 13.39 BRL | -1.10 | -2.99 | 1.1M | Off |
| 26 Jun 2026 | 15.61 BRL | 4.6% | 15.82 BRL | 13.38 BRL | -1.28 | -3.02 | 2.1M | Off |
| 19 Jun 2026 | 14.93 BRL | -1.6% | 15.80 BRL | 13.36 BRL | -1.39 | -4.57 | 2.0M | Off |
| 12 Jun 2026 | 15.18 BRL | 2.9% | 15.79 BRL | 13.35 BRL | -1.33 | -4.41 | 1.4M | Off |
| 5 Jun 2026 | 14.75 BRL | -4.2% | 15.78 BRL | 13.34 BRL | -1.25 | -5.94 | 2.7M | Off |
| 29 May 2026 | 15.39 BRL | -1.9% | 15.78 BRL | 13.32 BRL | -1.00 | -4.58 | 10.6M | Off |
| 22 May 2026 | 15.69 BRL | 0.6% | 15.73 BRL | 13.30 BRL | -0.92 | -4.02 | 10.0M | On |
| 15 May 2026 | 15.60 BRL | -5.9% | 15.66 BRL | 13.29 BRL | -0.85 | -5.05 | 11.2M | On |
| 8 May 2026 | 16.58 BRL | 3.1% | 15.63 BRL | 13.27 BRL | -0.64 | -2.73 | 10.4M | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.